Webinar: Medicinal cannabis reforms
Date
Last updated
Disclaimer
These presentation papers are provided on the TGA's website solely for the purpose of indicating or suggesting what TGA representatives spoke about to the various conferences and seminars to which it relates. The papers are not legislative in nature and should not be taken to be statements of any law or policy in any way.
The Australian Government Department of Health (of which the TGA is a part) advises that (a) the presentation papers should not be relied upon in any way as representing a comprehensive description of regulatory requirements, and (b) cannot guarantee, and assumes no legal liability or responsibility for, the accuracy, currency or completeness of the information contained in the presentation paper.
Presentation
- Presented by: Jennifer Burnett, Assistant Secretary, Manufacturing Quality Branch, TGA and Paul Crossley, Assistant Director, Manufacturing Quality Branch, TGA
- Presented at: Online
- Presentation date: Wednesday 6 April 2022
- Presentation summary: To provide information on the transition periods and how importers and sponsors can comply with the new requirements, due to reforms having been made to the manufacturing, labelling and packaging requirements for Medicinal Cannabis Products manufactured or supplied in Australia.
Webinar: Medicinal cannabis reforms (pdf,203kb)
Topics
-
Insights into Good Clinical Practice (GCP) Inspection Program activities 2023-2024
This webinar provides an overview of TGA’s Good Clinical Practice (GCP) Inspection Program clinical trial compliance activities. -
TGA Advisory Committees: Information for prospective applicants
Are you interested in applying to be a member of one of the TGA’s Statutory Advisory Committees? Hear first-hand from current members and the Chief Medical Adviser about what this exciting role is like. -
Proposed changes to IVD medical device classifications and definitions
Information session for external stakeholders about the proposed IVD regulation changes.